Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs

International Angiology

Volumn 17, Issue 2, 1998, Pages 97-102

  Mangiafico, R A ^a   Malatino, L S ^a   Santonocito, M ^a   Spada, R S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Arterial occlusive diseases; Chronic diseases; Diabetes mellitus, non insulin dependent; Endothelin 1

Indexed keywords

ENDOTHELIN 1; INSULIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; LEG ARTERY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; VASCULAR DISEASE;

ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIN-1; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 0031726856     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974;23:105-11.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1978;241:2035-8.
3. Whitehouse FW. Saving a foot and salving a limb. Diabetes Care 1979:2:391-5.
4. Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
5. Mangiafico RA, Malatino LS, Santonocito M, Spada RS, Polizzi G, Tamburino G. Raised plasma ET-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis. Int Anuiol 1996;15:240-4.
6. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990;33:306-10.
7. Kawamura M, Ohgawara H, Nanise M et al. Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 1992;15:1396-7.
8. Collier A, Leach JP, McLellan A, Morton JJ, Small M. Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992;15:1038-40.
9. Morise T, Takeuchi Y, Kawano M, Koni I, Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995;18:87-9.
10. Perfetto F, Tarquini R, de Leonardis V, Piluso A, Lombardi V, Tarquini B. Angiopathy affects circulatine ET-1 levels in type 2 diabetic patients. Acta Diabetol 1995;32:263-7.
11. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990;78:261-4.
12. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992;85:1927-38.
13. Boulanger C, Lusher TF. Release of endothelin from the porcine aorta, inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
14. Kourembanas S, Marsden PA, McQuillan LP, Fuller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-7.
15. Schini VB, Hendrickson H, Heublein D, Burnett J jr, Vanhoutte P. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 1989;165:333-4.
16. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T et al. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435-40.
17. Lowe GDO. Pathophysiology of critical limb ischaemia. In: Dormandy J, Stock G, editors. Critical Leg lschaemia: Its Pathophysiology and Management. Berlin: Springer-Verlag, 1990:17-38.
18. D'Angelo Y, Villa S, Myssllwlec M, Donati MB, de Gaetano G. Defective fibrinolytic and prostacyclin-like activity in human atherosclerotic plaques. Thromb Haemostas 1978;39:535-6.
19. Prins BA, Hu R-M, Nazario B, Pedram A, Frank HJ, Weber MA et al. Prostaglandin E2 and prostacyclin inhibit the production and the secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269:11938-44.
20. Ernst E, Dale E, Hammerschmidt MD, Bagge U, Matrai A, Dormandy J. Leucocytes and the risk of ischemic diseases. JAMA 1987;257:2318-24.
21. Nash GB, Thomas PRS, Dormandy JA. Abnormal flow properties of white cells in patients with severe ischaemia of the leg. Br Med J 1988;296:1699-701.
22. Neumann F-J, Waas W, Diehm C, Weiss T, Haupt HM, Zimmermann R et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation 1990;82:922-9.
23. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugijama T et al. Interleukin-1 increases the production of ET-1 by cultured endothelial cells. Biochem Biophvs Res Commun 1990;166:324-9.
24. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87(Suppl V):V67-V76.
25. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction. Br Heart J 1991;66:351-5.
26. Morise T, Takeuchi Y, Kawvano M, Koni I, Takeda R. Increased plasma levels of immunorcactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995;18:87-9.
27. Hu R, Levin ER, Pedram A, Frank HJL. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993;42:351-8.
28. Hattori Y, Kasai K, Makamura T, Emoto T, Shimoda S. Effects of glucose and insulin on immunoreactive ET-1 release from cultured porcine aortic endothelial cells. Metab Clin Exp 1991;40:165-9.
29. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Loeken MR, Shiba T et al. Stimulation of ET-1 gene expression by insulin in endothelial cells. J Biol Chem 1991;266:23251-6.
30. Rowe JW, Young JB, Mimaker KL, Stevens AL, Pallotta J, Landsberg L. Effects of insulin and glucose infusions on sympathetic nervous system activity in man. Diabetes 1981;30:219-25.
31. Vollenweidcr P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P et al. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993;92:147-54.
32. Nordt TK. Mechanisms responsible for attenuation of fibrinolysis in patients with non-insulin-dependent diabetes mellitus (Abstract). Circulation 1993;88:1-264.
33. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
34. Boulanger C, Lüsher TF. Nitric oxide and hirudin inhibit the thrombin-stimulaled release of endothelin from the intact aorta by two different mechanisms. Circ Res 1991;68:1768-72.
35. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ et al. Polar secretion of ET-1 by cultured endothelial cells. J Biol Chem 1992;267: 16066-8.
36. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989;1:150-4.
37. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-8.
38. Takagi Y, Fukase M, Takata S, Yoshimi H, Tokunaga O, Fujita T. Autocrine effect of endothelin on DNA syntesis in human vascular endothelial cells. Biochem Biophys Res Commun 1990;168:537-43.
39. Frank HJL, Levin ER, Hu R-M, Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 1993;133:1092-7.
40. Vane JR, Botting RM. Impact of risk factors on the endothelium. Cardiovasc Risk Factors 1994;4:108-21.
41. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M et al. Threshold concentrations of ET-1 potentiate contraction to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm. Circulation 1990;82: 188-95.
42. Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O et al. Circulating ET-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 1995;18:226-33.